More Avecho Biotechnology Limited news
Avecho Biotechnology LimitedASX: AVE

Phosphagenics collaboration to develop psoriasis drug

Mar 30, 2016 at 4:46 AM EDT · Issued by Avecho Biotechnology Limited

Filed with ASX · Mar 30, 2016 at 4:46 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/phosphagenics-collaboration-to-develop-psoriasis-drug

Avecho Biotechnology Limited on 6ix

Earlier from Avecho Biotechnology

  • Successful $24.1m Capital Raising and $3m SPPMar 30, 2016
  • POH Signs License Agreement with Intas PharmaceuticalsMar 30, 2016

Later from Avecho Biotechnology

  • Appointment of Joint CEO - Dr Esra OgruMar 30, 2016
  • December 2009 Appendix 4E and Statutory Financial ReportMar 30, 2016
  • June 2010 Half Yearly Appendix 4D and Financial ReportMar 30, 2016
All Avecho Biotechnology news releases↗

Follow Avecho Biotechnology into a list and get an email when it puts out news.

Follow Avecho Biotechnology
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer